Resources

Policies and resolutions

Essential medicines and health products – global overview

Finland national policy

Health 2020: a European policy framework supporting action across government and society for health and well-being (2013)

Eurohealth

Global initiative on health technologies

OECD Health

Back to top

Regulation and quality

Standardization of Biotherapeutic Products

List of European regulatory agencies

Quality assurance and safety of medicines

Substandard and Falsified (SF) Medical Products

United Nations Prequalification of Medicines Programme

Heads of Medicines Agencies

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)

European Union Pharmaceutical package

Ethical criteria for medicinal drug promotion (PDF, 28 KB)

WHO policies and resolutions on medical devices

Back to top

Health technology assessment

WHO headquarters

Health Technology Assessment International

European Network for Health Technology Assessment (EUnetHTA)

International Network of Agencies for Health Technology Assessment (INAHTA)

Adopting Hospital based Health Technology Assessment (AdHopHTA)

Back to top

Pricing and reimbursement

Reading list for pricing and reimbursement

Medicine price information sources

WHO guideline on country pharmaceutical pricing policies (2015)

WHO Collaborative Centre for Pharmaceutical Pricing and Reimbursement Policies

An overview of the Swedish system of pricing and reimbursement of pharmaceuticals

Fair pricing of medicines

Back to top

Responsible use of medicines

WHO Model Lists of Essential Medicines

Summaries of changes to the WHO Model List of Essential Medicines (EML) and Model List of Essential Medicines for children (EMLc) 2017

Summaries of changes to the WHO Model List of Essential Medicines (EML) and Model List of Essential Medicines for children (EMLc) 2019

French National Authority for Health (Haute Authorité de Santé) (in French)

National Institute for Health and Care Excellence (NICE), United Kingdom

Scottish Intercollegiate Guidelines Network (SIGN)

German Institute for Quality and Efficiency in Health Care

Back to top

Biosimilars

Biosimilar medicines from the European Medicines Agency

Standardization of Biotherapeutic Products

Back to top